000			01859 a2200529 4500
005			20250516063648.0
264		0	_c20120507
008			201205s 0 0 eng d
022			_a1769-6690
024	7		_a10.1016/j.medmal.2011.10.002 _2doi
040			_aNLM _beng _cNLM
100	1		_aLanoix, J-P
245	0	0	_aSphingomonas paucimobilis bacteremia related to intravenous human immunoglobulin injections. _h[electronic resource]
260			_bMedecine et maladies infectieuses _cJan 2012
300			_a37-9 p. _bdigital
500			_aPublication Type: Letter
650	0	4	_aAgammaglobulinemia _xtherapy
650	0	4	_aAnti-Bacterial Agents _xtherapeutic use
650	0	4	_aBacteremia _xdrug therapy
650	0	4	_aCatheter-Related Infections _xdrug therapy
650	0	4	_aCatheterization, Central Venous _xadverse effects
650	0	4	_aCross Infection _xdrug therapy
650	0	4	_aDrug Contamination
650	0	4	_aEquipment Contamination
650	0	4	_aFemale
650	0	4	_aGram-Negative Bacterial Infections _xdrug therapy
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aImmunoglobulins, Intravenous _xadministration & dosage
650	0	4	_aLymphoma, Follicular _xcomplications
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aNeutropenia _xchemically induced
650	0	4	_aPostoperative Complications _xtherapy
650	0	4	_aSphingomonas _xisolation & purification
650	0	4	_aYoung Adult
700	1		_aHamdad, F
700	1		_aBorel, A
700	1		_aThomas, D
700	1		_aSalle, V
700	1		_aSmail, A
700	1		_aEl Samad, Y
700	1		_aSchmit, J-L
773	0		_tMedecine et maladies infectieuses _gvol. 42 _gno. 1 _gp. 37-9
856	4	0	_uhttps://doi.org/10.1016/j.medmal.2011.10.002 _zAvailable from publisher's website
999			_c21304017 _d21304017